The authors concluded that preliminary evidence suggests that cognitive-behavioural treatment shows potential for treating young children with obsessive-compulsive disorder, but further research is required. Although the authors' cautious conclusions appear to reflect the limited evidence from observational data, the lack of information about individual studies and review methods hinders an adequate assessment of the robustness of these conclusions.
Authors' objectives
To evaluate the efficacy of cognitive-behavioural treatment (CBT) for the treatment of young children with obsessive compulsive disorder (OCD) and to define gaps in the research. This abstract focuses on the quantitative review of efficacy.
Searching
MEDLINE and PsycLIT were searched using the reported keywords. In addition, reference lists of articles and major reviews of OCD were screened, and experts in OCD were contacted for details of published and unpublished studies. Only studies with an English language report were included in the quantitative review.
Study selection Study designs of evaluations included in the review
Inclusion criteria were not specified in terms of the study design. Only studies with more than 10 patients per cell were included in the quantitative review.
Specific interventions included in the review
Studies that evaluated CBT were eligible for inclusion in the review. The included studies evaluated individual, group and family CBT, and a combination of CBT plus medication.
Participants included in the review
Studies of children/adolescents aged 5 to 17 years were eligible for inclusion. It was clear that the review focused on children with OCD but the review did not define criteria for the diagnosis of OCD. A proportion of participants in most of the included studies were also on medication. The average age of the participants ranged from 11.3 to 15.2 years.
Outcomes assessed in the review Inclusion criteria were not specified in terms of the outcomes. Studies had to report sufficient information to allow the calculation of a pre-treatment post-treatment effect size to be included in the quantitative review. All but two of the studies included in the quantitative review used Children's Yale-Brown Obsessive Compulsive Scale as the primary outcome measure; other studies used a severity rating or the National Institutes of Mental Health Obsessive Compulsive Scale.
How were decisions on the relevance of primary studies made?
